June 13, 2017
Evolution is a propulsive force, working incessantly to reshape life on earth, from the lowliest single-celled organisms to the planets vast forests, insect and bird populations, oceanic life and diverse mammalian species.
Like all living things, cancer cells are also subject to the stringent dictates of evolution. Indeed, cancer has proven to be among the most adept players in natures ceaseless game. Evolution is the reason humans and other life forms are vulnerable to cancer and why the disease has been so challenging to cure. Carlo Maley's research focuses on evolution and cancer biology. He is a researcher in the Biodesign Center for Personalized Diagnostics and an associate professor in the School of Life Sciences at ASU. Download Full Image
In a new book, "Frontiers in Cancer Research: Evolutionary Foundations, Revolutionary Directions," (Springer, 2017), Carlo Maley, a researcher at Arizona State University's Biodesign Institute, illuminates some of the central issues in current cancer study, from the vantage point of evolutionary and ecological theory. The book features chapters written by a range of researchers at the vanguard of the field. Their aim is to highlight some of the most intriguing unanswered questions in cancer research and to propose evolution-based strategies for addressing them.
Ignoring evolutionary transformation cancers primary weapon of destruction has limited progress toward the successful treatment and possible prevention of cancer. By the same token, the authors argue, the rules of evolution, if properly understood and applied, may help science to outwit cancer, either driving it to extinction or curtailing its lethality.
The book begins with a call to arms in the fight against cancer: Nearly everyone working on cancer biology is actually working on evolutionary biology, even if they do not realize it, Maley said. Unfortunately, we suffer from a paucity of evolutionary biologists and ecologists who are studying cancer. The following chapters deliver a rallying cry for other innovative researchers to enter the field and contribute their talents.
Historically, biology has been a largely experimental discipline. Charles Darwin, however, provided a theoretical framework for understanding living systems, a master narrative capable of accounting for the diversity of earthly life, through simple laws. Intriguingly, the twin forces of chance mutation and natural selection also provide cancer cells with their tenacious ability to carve out a hospitable niche, compete for resources and expand their reign at the expense of their host.
The wide-ranging text covers the genetics of cancer populations, genetic diversity within tumors (intra-tumor heterogeneity), the expansion of mutant clones, cancer stem cells in the dynamics of tumors, the evolution of metastasis, and techniques for improving cancer therapy through monitoring cancers evolutionary response to treatment.
Additional chapters address the patterns of human cancer susceptibility due to a mismatch between modern environments and those in which our species evolved, as well as the evolution of cancer suppression mechanisms that have emerged in different species; particularly the large long-lived animals like elephants and whales that are better at suppressing cancers than humans. Perhaps these adaptations can provide new sights relevant for human therapy and cancer prevention.
The topic of cancer heterogeneity is a central theme of the book. The existence of a wide variety of mutant cells usually present in the patient before initial diagnosis presents the most formidable challenge to effective treatment. The authors propose that such diversity is so ubiquitous that it may be applied as a universal biomarker an early warning beacon indicating the propensity for cancer development or the severity of the particular cancer diagnosis. Diversity may therefore provide a common denominator, useful for tracking and characterizing cancers through all their bewildering subtypes.
In addition to disease diagnosis, measures of cancer cell diversity may also help guide the course of therapy. Here, the authors stress a central misconception in conventional cancer treatment one which persists in spite of evolutionary theory. Efforts to eradicate all cancerous cells in a diverse population effectively select for those cells resistant to treatment. Eliminating evolutionary competition between varying cell types allows resistant post-treatment cells to expand without limit, forming a sort of super-charged cancer, less susceptible to management.
The authors trace the history of the current impasse in cancer treatment, attributing it in part to the revolution in molecular biology, which may have unwittingly acted to sideline evolutionary approaches. Clinical methods that met with enormous success in treating viral and bacterial infections have proven largely impotent against the protean nature of cancer, which, unlike a foreign pathogen, is a moving target comprised of the hosts own cells.
As John W. Pepper of the National Cancer Institute writes in the book: ... cancer cells are genetically heterogeneous but fundamentally human, as opposed to infectious cellular diseases that are homogeneous and fundamentally non-human. Clearly, a reevaluation of reductionist tactics will be critical in breaking the treatment stalemate. Magic-bullet approaches to cancer, the authors argue, have dominated clinical thinking but have largely amounted to dead ends.
The dynamic nature of evolution poses particular challenges for cancer research and treatment. Cancers are often diagnosed at a single time point, with one sample per tumor, an approach that masks the subtle evolutionary processes driving cancer progression. A transition to multiple sampling to yield a more representative, time-sensitive picture of tumor evolution is encouraged, though at present, this is often cost- and time-prohibitive.
A popular theory declares that not all cancer cells are created equal. Even cells that are genetically identical may behave differently. In this view, so-called cancer stem cells, which are distinct from neighboring cancer cells in that they are self-restoring, act to drive the progression of the disease, with surrounding cells acting merely as bystanders. From the standpoint of treatment, cancer stem cells are of central concern and a failure to eradicate them will inevitably lead to regrowth of the tumor.
Chapter 8 is devoted to cancers most lethal attribute, its ability to spread from the region of primary malignancy to other areas of the body, a phenomenon known as metastasis. Indeed, most cancer fatalities are the result of metastasis. Here again, research has only scratched the surface in terms of understanding the subtle particulars driving this aspect of cancer. What seems clear is that metastasizing cells often display greater aggressiveness and adaptability compared with their primary tumor counterparts. Thwarting metastasis is therefore among the primary objectives of ongoing research, with evolutionary models paving the way for new insights.
Given the selective pressure exerted by anti-cancer drugs, which cause Darwinian dynamics to select for treatment-resistant cells, what alternatives exist? One of the most exiting clinical innovations resulting from an evolutionary re-thinking of cancer is described by Robert Gatenby, a pioneer in what is known as adaptive therapy.
The basic idea is to maintain cells in the tumor that remain sensitive to the therapy so that they can out-compete resistance cells. The goal is to maintain the tumor at a stable size. So, when the tumor shrinks in response to therapy, the oncologist lowers the dose, but when it grows, she raises the dose. The aim is to stabilize the tumor by insuring active intra-tumor competition, rather than attempt to kill a maximum number of cells via conventional chemotherapy or radiation. The method is likened by Gatenby to the predator-prey arms race often seen in adaptive landscapes of differing species.
How can we deal with the evolutionary resilience of cancer? The sobering conclusion of the book stresses cancers virtually limitless capacity to reemerge in new, resistant guises due to compulsive evolution, a fact that may continue to sabotage our best efforts to shut it down. Prevention and the earliest possible interventions when heterogeneity may still be limited offer the best chances in the near term for beating this implacable illness. Time is the enemy.
Link:
New book by ASU researcher explores cancer's pervasive mysteries - Arizona State University
- Arizona Oncology Cancer Center working with NexCore Group on new cancer treatment center - Yahoo Finance - October 13th, 2022
- Senate Passes 'Inflation Reduction Act' Which Will Likely Make Inflation Worse - Reason - August 14th, 2022
- Reds prospect rankings will shift after trade deadline acquisition of 10 players - The Athletic - August 5th, 2022
- Stem Cell Therapy Pros and Cons - Arizona Pain and Spine Institute - July 11th, 2022
- Bone Anatomy | Ask A Biologist - Arizona State University - July 11th, 2022
- No, "Top Gun" isn't an anti-woke success story, but rather a tribute to aging Tom Cruise and balls - Salon - June 4th, 2022
- Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Lewiston Sun Journal - June 4th, 2022
- BioEclipse Therapeutics Awarded Almost $8 Million Grant by California Institute for Regenerative Medicine (CIRM) to Fund Ongoing Phase 1 CRX100 Cancer... - May 2nd, 2022
- Right to Try 2.0: Ahwatukee family pushes for proposed law after getting medical treatment abroad - FOX 10 News Phoenix - April 6th, 2022
- Inside the real life Noahs Ark designed to save mankind after the apocalypse with a back up vault on t... - The US Sun - January 5th, 2022
- Human Embryonic Stem Cells - Arizona State University - November 22nd, 2021
- Mindy Kaling's 'The Sex Lives of College Girls' Is a Spot-On Depiction of College - Glamour - November 22nd, 2021
- Bridging the gap between online and on campus - ASU Now - November 22nd, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- ASU professor researches origins of Alzheimers to find a cure - Eight, Arizona PBS - October 16th, 2021
- City of Hope to Accelerate Blood Cancer Research Through a Transformational Gift from Leukemia Survivor James Belardi and His Wife Leslie Belardi -... - October 5th, 2021
- Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope and the University of Chicago for Novel Oncolytic Virotherapy... - August 18th, 2021
- Jim McMahon broke his neck playing for Vikings, and found out about it 17 years later - TwinCities.com-Pioneer Press - December 23rd, 2020
- Want to Know Where The Best Fall Colors Are in Your Area? Check Out This Interactive US Map - Good News Network - October 5th, 2020
- 'Were not your slaves': Alternative health providers bristle at warning letters about their coronavirus treatments - USA TODAY - September 4th, 2020
- Neogene precipitation, vegetation, and elevation history of the Central Andean Plateau - Science Advances - September 4th, 2020
- Research Roundup: Lasting Immunity to COVID-19 and More - BioSpace - August 21st, 2020
- What in the world is 'Project Carpaccio' and which Israeli company is doing business in Abu Dhabi? - CTech - August 21st, 2020
- Viruses have big impacts on ecology and evolution as well as human health - The Economist - August 21st, 2020
- Encouraging News About Coronavirus Immunity | In the Pipeline - Science Magazine - August 21st, 2020
- Scientists are seeing signs of lasting immunity to COVID-19, among survivors with even mild infections - Firstpost - August 21st, 2020
- Studies show positive signs of strong, lasting Covid-19 immunity - The Irish Times - August 21st, 2020
- Coronavirus vaccine will take time, so researchers are hunting for and finding promising new COVID-19 tre - OregonLive - April 6th, 2020
- Penn announces seven 2020 Thouron Award winners - Penn: Office of University Communications - February 24th, 2020
- Unlocking The Secrets Of DNA Help Researchers Understand How to Slow Aging - YouAreUNLTD - January 9th, 2020
- An ESPN reporter was diagnosed with HLH just before he died at age 34. What is it? - ABC15 Arizona - January 2nd, 2020
- 2020s visions: We'll get flying cars just before becoming software-based people - CNET - December 19th, 2019
- Man fights $4,600 surgery bill he was told insurance would cover - KGUN - December 8th, 2019
- Professor Recognized For Cardiac Regeneration Research - WPI News - December 8th, 2019
- Creative Medical Technology Holdings, Inc. Discusses CaverStem and Other Patented Technology with The Stock Day Podcast - Yahoo Finance - October 19th, 2019
- Bone marrow recipient comes face-to-face with CT donor for the first time - WTNH.com - October 19th, 2019
- Positive Study Results of Phase IIa Clinical Trial Using Intravenous Administration of Mesenchymal Stem Cells for Ischemic Stroke Published in... - October 1st, 2019
- Stem Cell Education Center - Stem Cell Treatment | Arizona ... - September 14th, 2019
- Stem Cell Therapy In Scottsdale Arizona | Regenerative ... - September 12th, 2019
- Stem Cell Therapy | Board Certified Orthopedic Surgeon ... - March 16th, 2019
- Stem Cell Lake Havasu City Arizona 86406 - March 8th, 2019
- Stem Cell Therapy for Cancer | Arizona Pain and Spine ... - December 18th, 2018
- Stem Cells | Arizona Pain Specialists - Scottsdale ... - December 11th, 2018
- Arizona Pain Regenerative Institute - Arizona Pain Specialists - December 5th, 2018
- Stem Cell Therapy Phoenix Arizona | Desert Health Specialists - December 4th, 2018
- Southwest Spine and Sports - Pain Management Doctor Arizona - September 24th, 2018
- Celebration Stem Cell Centre - A private umbilical cord ... - August 12th, 2018
- Bone marrow transplant - Mayo Clinic - July 15th, 2018
- About Dr. Nabil Dib - June 27th, 2018
- Around the world - Bend Bulletin - August 30th, 2017
- FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments - KNAU Arizona Public Radio - August 30th, 2017
- BrainStorm Supports Commitment to ALS Patient Community with ... - Markets Insider - August 8th, 2017
- ASU grad students' lab skills help earn funding for cutting-edge biomedical research - Arizona State University - August 8th, 2017
- Will putting leeches on his face help this blind man see? - USA TODAY - August 8th, 2017
- Engineered Skin Cells Control Type 2 Diabetes in Mice: Study ... - Arizona Daily Star - August 8th, 2017
- 'Soft' side of bioengineering poised to make big impacts - Arizona State University - August 4th, 2017
- Tackling hard-to-treat cancers from every angle - Medical Xpress - June 21st, 2017
- ALS Research Forum | To Evaluate Stem Cell Therapies, Think ... - ALS Research Forum - June 20th, 2017
- Arizona Supreme Court Clears Way For Adoption of American Indian Child by Non-Native Parents - Reason (blog) - June 15th, 2017
- Can We Cheat Death? US Firm Aims To Resurrect Brain-Dead People Using Stem Cells - International Business Times - June 11th, 2017
- The three cancers Jews need to worry about most and how to reduce the risks - Jewish Post - June 11th, 2017
- Patient-Centered Stem Cell Therapy Bill Passed by Texas Legislature - satPRnews (press release) - May 31st, 2017
- 6 Arizona young women are taking on the STEM gender gap - AZCentral.com - May 28th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Texas Tribune - May 26th, 2017
- Scientists wary as Texas mulls allowing sale of unproven drugs - Bryan-College Station Eagle - May 24th, 2017
- ASU engineers envision 'guiding' body's cells to help improve health - Arizona State University - May 19th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol | Sun Life ... - Sahuarita Sun (subscription) - May 19th, 2017
- Derek McCartney Named To Lott IMPACT Trophy Watch List - KKTV 11 News - May 18th, 2017
- Tucson Tech: University of Arizona startup advances living heart patch - Arizona Daily Star - May 15th, 2017
- Scientists uncover root of graying, thinning hair - Arizona Daily Star - May 15th, 2017
- GV Gardeners: Sun-loving saguaro Southwest symbol - Green Valley News - May 15th, 2017
- 7-year-old Hollis spread joy around U.S. After losing him to rare brain tumor, parents turn to finding cure - AZCentral.com - May 1st, 2017
- Young minds meet new technology at STEM-focused after-school program - USC News - April 19th, 2017
- Applications for Tissue Culture in Cannabis Growing: Part 1 - Cannabis Industry Journal (blog) - April 14th, 2017
- Yankees: James Kaprielian Getting Tommy John Surgery Out of the Way - Yanks Go Yard - April 14th, 2017
- Can Stem Cell 'Patch' Help Heart Failure? - Arizona Daily Star - April 9th, 2017
- Angels' focus is on defense - Reading Eagle - April 2nd, 2017
- Some restoration drama at the Big A as Dodgers top Angels, 3-1 - Los Angeles Times - April 1st, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 10th, 2017
- R. William Funk Lands New Leader for University of Arizona - Hunt Scanlon Media (press release) - March 9th, 2017